Featured: imatinib, Gleevec Main Article
Imatinib (Gleevec) is a kinase inhibitor prescribed for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. Side effects, drug interactions, dosing information, and warnings and precautions should be reviewed prior to taking any medication.
Related Diseases & Conditions
Related FAQs, Doctor's & Expert's Views
View All 7 imatinib-oral Doctor's & Expert's Views »
Tools & References
FDA Drug Labels on RxList.com